Literature DB >> 25131333

Dietary squid ink polysaccharides ameliorated the intestinal microflora dysfunction in mice undergoing chemotherapy.

Qingjuan Tang1, Tao Zuo, Shangyun Lu, Juan Wu, Jianghua Wang, Rong Zheng, Shiguo Chen, Changhu Xue.   

Abstract

Gastrointestinal mucositis and infection by chemotherapy treatment are associated with alteration of intestinal microflora and bacterial translocation due to the potential damage induced by anti-cancer drugs on the intestinal barrier and microbiota homeostasis. This study aimed to investigate the protective effect of dietary polysaccharides on chemotherapy induced intestinal microflora dysfunction. In the current contribution, with a mouse model intraperitoneally injected with 50 mg kg(-1) of cyclophosphamide (Cy) for 2 days, we revealed that polysaccharides from the ink of Ommastrephes bartrami (OBP) altered the intestinal microflora composition. OBP retarded the excessive growth of intestinal bacteria induced by cyclophosphamide, based on 16S rRNA gene (16S rDNA) quantification. The clone libraries of intestinal bacteria 16S rDNA were used to decipher the difference in bacterial community structures in different groups of mice. Followed by RFLP evaluation and OTU abundance analysis, they imply that OBP changed the intestinal microflora composition, in which the quantity of probiotic Bifidobacterium got up-regulated but Bacteroidetes decreased in mice undergoing chemotherapy. Our results may have important implications for OBP as a functional food component or nutrient against chemotherapy induced intestinal injury and potential pathogenic intestinal disorders involving inflammation and infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25131333     DOI: 10.1039/c4fo00408f

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  8 in total

Review 1.  Gut microbiota modulation of chemotherapy efficacy and toxicity.

Authors:  James L Alexander; Ian D Wilson; Julian Teare; Julian R Marchesi; Jeremy K Nicholson; James M Kinross
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

Review 2.  The pathogenesis of mucositis: updated perspectives and emerging targets.

Authors:  J Bowen; N Al-Dasooqi; P Bossi; H Wardill; Y Van Sebille; A Al-Azri; E Bateman; M E Correa; J Raber-Durlacher; A Kandwal; B Mayo; R G Nair; A Stringer; K Ten Bohmer; D Thorpe; R V Lalla; S Sonis; K Cheng; S Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.603

3.  Inhibition of chemotherapy-induced apoptosis of testicular cells by squid ink polysaccharide.

Authors:  Yi-Peng Gu; Xiao-Mei Yang; Zhen-Hua Duan; Ping Luo; Jiang-Hua Shang; Wei Xiao; Ye-Xing Tao; Da-Yan Zhang; Yun-Bo Zhang; Hua-Zhong Liu
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

Review 4.  A Potential Adjuvant Agent of Chemotherapy: Sepia Ink Polysaccharides.

Authors:  Fangping Li; Ping Luo; Huazhong Liu
Journal:  Mar Drugs       Date:  2018-03-28       Impact factor: 5.118

5.  Houttuynia cordata polysaccharide alleviated intestinal injury and modulated intestinal microbiota in H1N1 virus infected mice.

Authors:  Mei-Yu Chen; Hong Li; Xiao-Xiao Lu; Li-Jun Ling; Hong-Bo Weng; Wei Sun; Dao-Feng Chen; Yun-Yi Zhang
Journal:  Chin J Nat Med       Date:  2019-03

6.  Antioxidant and Immunostimulatory Activities of Fermented Sour Soybean Milk Added With Polypeptides From Pleurotus eryngii.

Authors:  Xinling Song; Ximin Xu; Wei Chen
Journal:  Front Microbiol       Date:  2022-06-15       Impact factor: 6.064

Review 7.  Does the gut microbiome environment influence response to systemic breast cancer treatment?

Authors:  Eilidh Bruce; Stanislau Makaranka; Gordon Urquhart; Beatrix Elsberger
Journal:  Explor Target Antitumor Ther       Date:  2021-08-30

8.  Squid ink polysaccharide reduces cyclophosphamide-induced testicular damage via Nrf2/ARE activation pathway in mice.

Authors:  Xiaoyan Le; Ping Luo; Yipeng Gu; Yexing Tao; Huazhong Liu
Journal:  Iran J Basic Med Sci       Date:  2015-08       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.